RYAN E HALL M.D. NPI 1366761975

NPI Details

Ryan E Hall, M.D. is a hematology and oncology internal medicine in Little Rock, AR with 16 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Ryan E Hall, M.D. NPI is 1366761975. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Graduation Year:2010

The provider's business location address is:

8901 CARTI WAY
LITTLE ROCK, AR
ZIP 72205-523
Phone: (501) 906-3000
Fax: (501) 907-8367

The NPI 1366761975 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, pemetrexed, not otherwise specified, 10 mg (HCPCS:J9305)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Ferritin (blood protein) level (HCPCS:82728)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Unclassified drugs (HCPCS:J3490)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection, doxorubicin hydrochloride, 10 mg (HCPCS:J9000)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Protein measurement, serum (HCPCS:84165)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Magnesium level (HCPCS:83735)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Erythropoietin (protein) level (HCPCS:82668)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Nephelometry, test method using light (HCPCS:83883)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Vitamin d-3 level (HCPCS:82306)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Uric acid level, blood (HCPCS:84550)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Injection of drug or substance into vein (HCPCS:96374)
• Blood test, clotting time (HCPCS:85610)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Drawing of blood for a medical problem (HCPCS:99195)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Phosphate level (HCPCS:84100)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Blood creatinine level (HCPCS:82565)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Cortisol (hormone) measurement, total (HCPCS:82533)

The enumeration date for this NPI number is 5/21/2010 and was last updated on 3/10/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: